Pulse Biosciences IncのCurrent ratio
Pulse Biosciences IncのCurrent ratioは何ですか。
Pulse Biosciences IncのCurrent ratioは4.57です。
Current ratioの定義は何ですか。
流動比率は、同社が短期債務を履行するために十分なリソースを持っているかどうかを測定流動性比率です。
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
NASDAQのセクタHealth CareにおけるCurrent ratioの企業と比べるPulse Biosciences Inc
Pulse Biosciences Incは何をしますか。
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Pulse Biosciences Incと類似のcurrent ratio
- Aldeyra Therapeutics IncのCurrent ratioは4.55です。
- Zoom Video Communications IncのCurrent ratioは4.56です。
- Douyu International LtdのCurrent ratioは4.56です。
- BIT Mining LtdのCurrent ratioは4.56です。
- Achieve Life SciencesのCurrent ratioは4.56です。
- Midwich PlcのCurrent ratioは4.57です。
- Pulse Biosciences IncのCurrent ratioは4.57です。
- CIM Commercial TrustのCurrent ratioは4.58です。
- Hongkong ChineseのCurrent ratioは4.58です。
- Nuveen California Municipal Value FundのCurrent ratioは4.58です。
- Talga ResourcesのCurrent ratioは4.58です。
- InkeのCurrent ratioは4.58です。
- Mayur UniquotersのCurrent ratioは4.58です。